Omega-3 supplementation for parents and adolescents to reduce behavior problems
Omega-3 Supplementation to Both Parent and Adolescent to Reduce Behavior Problems
PHASE3 · Joint Child Health Project, Mauritius · NCT05893550
This study is testing if giving omega-3 supplements to both parents and teenagers can help reduce behavior problems in kids aged 11 to 18.
Quick facts
| Phase | PHASE3 |
|---|---|
| Study type | Interventional |
| Enrollment | 800 (estimated) |
| Ages | 11 Years to 50 Years |
| Sex | All |
| Sponsor | Joint Child Health Project, Mauritius (other) |
| Locations | 1 site (Quatre Bornes) |
| Trial ID | NCT05893550 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of omega-3 supplementation on reducing externalizing behavior problems in adolescents aged 11 to 18 and their parents. It employs a randomized, double-blind, placebo-controlled design to assess whether dual supplementation can lead to greater improvements in behavior compared to single supplementation. The study also aims to explore the underlying mechanisms by which omega-3 impacts behavior. The overarching goal is to develop a non-invasive approach to prevent youth aggression and adult violence.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 11 to 18 who are willing to participate and have a parent involved in the prior Mauritius Child Health Project.
Not a fit: Patients with allergies to fish or fish products, intellectual disabilities, or those who have used fish oil supplements in the past six months may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce behavior problems in adolescents, potentially leading to lower rates of aggression and violence in adulthood.
How similar studies have performed: Previous studies have shown promising results with omega-3 supplementation in reducing behavior problems, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * adolescents between Age 11 and 18 * willing to participate in a randomized control trial * parent participated in prior Mauritius Child Health Project Exclusion Criteria: * Allergy to fish or fish products * Intellectual disability * Use of fish oil supplementations in the past 6 months
Where this trial is running
Quatre Bornes
- Joint Child Health Project — Quatre Bornes, Mauritius (RECRUITING)
Study contacts
- Principal investigator: Adrian Raine, D.Phil. — University of Pennsylvania
- Study coordinator: Tashneem Mahoomed, BSc
- Email: jchp2010@gmail.com
- Phone: 00230 52524414
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Behavior Problems